Mednet Logo
HomeQuestion

Do you dose escalate a patient with high risk prostate cancer who refuses ADT due to potential side effects?

3 Answers
Mednet Member
Mednet Member
Radiation Oncology · Stony Brook University School of Medicine

I would treat the elective pelvis to around 50 Gy with a simultaneous boost to the LN to as high as tolerable based on proximity to the bowel. The prostate should be taken to normal dose-escalated levels depending on your fractionation, and you can add a microboost to a DIL. I generally do not add a...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center

I would treat with standard options of definitive EBRT to prostate and gross node, as feasible based on location and OAR tolerance, along with elective dosing to pelvic nodal basins up to likely the aortic bifurcation.

I would not escalate further than normal EBRT doses. Consideration could be give...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Marshfield Clinic - Rice Lake

First, I'd get a PSMA PET scan to check for bony mets, and assuming it was negative, would try again to convince the patient to take at least a short course of androgen ablation.

Assuming he continued to refuse androgen ablation, I'd take the prostate and involved nodes to 70 @ 2.5/d, with the clini...

Register or Sign In to see full answer

Do you dose escalate a patient with high risk prostate cancer who refuses ADT due to potential side effects? | Mednet